Skip to main content

Table 3 Multivariate logistic regression analysis of predictive factors for treatment response in each lesion

From: Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab

Parameter

Category

P-value

OR

95% CI

Age

―

0.372

0.846

0.586–1.222

Gender

male

 

1

 

female

0.274

0.116

0.002–5.503

Baseline diameter

―

0.999

1.000

0.960–1.042

Baseline SUVmax

―

0.866

1.069

0.494–2.311

Metastatic site

lung

 

1

 

non-lung

0.271

3.215

0.403–25.665

Elevation of SUVmax

no

 

1

 

yes

0.025

13.087

1.373–124.716

Decrease in diameter

no

 

1

 

yes

0.313

2.889

0.367–22.731

  1. CI Confidence interval, OR Odds ratio